English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 56552/90363 (63%)
造訪人次 : 11824930      線上人數 : 151
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library & TKU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    請使用永久網址來引用或連結此文件: http://tkuir.lib.tku.edu.tw:8080/dspace/handle/987654321/61568

    題名: Downregulation of HER2 by RIG1 involves the PI3K/Akt pathway in ovarian cancer cells
    作者: Ou, Chien-Chih;Hsu, Shih-Chung;Hsieh, Yin-Hui;Tsou, Wan-Ling;Chuang, Tzu-Chao;Liu, Jah-Yao;Kao, Ming-Ching
    貢獻者: 淡江大學化學學系
    日期: 2008-02
    上傳時間: 2013-05-31 11:35:31 (UTC+8)
    出版者: Oxford: Oxford University Press
    摘要: Interferon-γ (IFN-γ) is known to downregulate HER2 oncoprotein (p185HER2 or briefly p185) in prostate cancer cells. We demonstrate that the IFN-γ-induced retinoid-inducible gene 1 (RIG1) acts as a transrepressor of p185. Furthermore, we exhibit that RIG1 downregulates the activated (phosphorylated) form of p185 and phosphoinositide-3 kinase (PI3K)/serine/threonine-specific protein kinase (Akt) and the mammalian target of rapamycin (mTOR), downstream substrates of HER2. We also elucidate that heregulin (HRG) specifically restores the activation of p185 and Akt after their activities are reduced by RIG1. Additionally, expression of vascular endothelial growth factor (VEGF) increases through the HER2- and Akt/mTOR-signaling pathways, indicating that VEGF is downregulated by RIG1 within the cell. These findings suggest that RIG1 plays a role in IFN-γ-mediated therapy by downregulating p185 and its downstream PI3K/Akt/mTOR/VEGF-signaling pathway. These results may provide a new therapeutic mechanism for the clinical use of IFN-γ and RIG1.
    關聯: Carcinogenesis 29(2), pp.299-306
    DOI: 10.1093/carcin/bgm263
    顯示於類別:[化學學系暨研究所] 期刊論文


    檔案 大小格式瀏覽次數



    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library & TKU Library IR teams. Copyright ©   - 回饋